COLIZZI, Marco
 Distribuzione geografica
Continente #
AS - Asia 4.537
NA - Nord America 2.737
EU - Europa 1.576
SA - Sud America 760
AF - Africa 99
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.723
Nazione #
SG - Singapore 2.799
US - Stati Uniti d'America 2.598
BR - Brasile 619
IT - Italia 597
CN - Cina 589
HK - Hong Kong 405
VN - Vietnam 319
RU - Federazione Russa 210
FR - Francia 169
DE - Germania 125
IE - Irlanda 100
IN - India 90
GB - Regno Unito 75
BD - Bangladesh 64
CA - Canada 60
KR - Corea 58
AR - Argentina 54
FI - Finlandia 51
MX - Messico 48
NL - Olanda 48
AT - Austria 38
IQ - Iraq 31
TR - Turchia 28
ES - Italia 27
ID - Indonesia 26
EC - Ecuador 24
PL - Polonia 24
BE - Belgio 22
ZA - Sudafrica 21
CO - Colombia 20
DK - Danimarca 19
PK - Pakistan 19
JP - Giappone 18
UZ - Uzbekistan 15
EG - Egitto 13
IL - Israele 12
MA - Marocco 12
TG - Togo 12
CL - Cile 11
SE - Svezia 11
UA - Ucraina 11
AU - Australia 10
VE - Venezuela 10
TN - Tunisia 9
ET - Etiopia 8
PY - Paraguay 8
SA - Arabia Saudita 8
CR - Costa Rica 7
CZ - Repubblica Ceca 7
DZ - Algeria 7
JO - Giordania 7
PH - Filippine 7
RS - Serbia 6
BG - Bulgaria 5
HN - Honduras 5
PA - Panama 5
PE - Perù 5
PS - Palestinian Territory 5
RO - Romania 5
CH - Svizzera 4
HU - Ungheria 4
KE - Kenya 4
LB - Libano 4
LT - Lituania 4
NP - Nepal 4
AO - Angola 3
BO - Bolivia 3
GY - Guiana 3
JM - Giamaica 3
LK - Sri Lanka 3
MY - Malesia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PT - Portogallo 3
TH - Thailandia 3
UY - Uruguay 3
BN - Brunei Darussalam 2
BY - Bielorussia 2
DM - Dominica 2
DO - Repubblica Dominicana 2
HR - Croazia 2
IR - Iran 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
MU - Mauritius 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
CU - Cuba 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
LC - Santa Lucia 1
Totale 9.709
Città #
Singapore 711
Hong Kong 402
Ashburn 361
Beijing 261
Chandler 250
San Jose 205
The Dalles 150
Boardman 139
Lauterbourg 133
Ho Chi Minh City 123
Los Angeles 99
Dublin 98
Council Bluffs 92
Dallas 86
Princeton 84
São Paulo 67
Milan 64
Hanoi 57
Rome 57
Seoul 57
Hefei 56
Redondo Beach 56
Buffalo 47
Toronto 40
Orem 31
Trieste 31
Andover 30
Frankfurt am Main 30
New York 30
Nuremberg 29
Santa Clara 29
Chicago 24
Helsinki 23
Lappeenranta 23
Vienna 23
Hyderabad 22
Brussels 21
Ogden 20
Rio de Janeiro 19
Copenhagen 18
Munich 18
Denver 17
Udine 17
Brooklyn 16
Düsseldorf 16
Venice 16
Warsaw 16
Amsterdam 15
Mexico City 15
Tokyo 15
Baghdad 14
Brasília 14
Haiphong 14
Ningbo 13
Tashkent 13
Atlanta 12
Chennai 12
Dhaka 12
Istanbul 12
Johannesburg 12
Lomé 12
Mumbai 12
Montreal 11
Verona 11
Da Nang 10
Naples 10
Porto Alegre 10
Portsmouth 10
Stockholm 10
Boston 9
Campinas 9
Can Tho 9
London 9
Poplar 9
Curitiba 8
Guangzhou 8
Guayaquil 8
Porcia 8
Seattle 8
Shanghai 8
Treviso 8
Belo Horizonte 7
Florence 7
Houston 7
Manchester 7
Quito 7
Salvador 7
Spinea 7
Belluno 6
Benito Juarez 6
Bergamo 6
Cairo 6
Columbus 6
Guarulhos 6
Hải Dương 6
Jakarta 6
Perugia 6
Pune 6
Ribeirão Preto 6
Santo André 6
Totale 4.705
Nome #
Therapeutic Effect of Palmitoylethanolamide in Cognitive Decline: A Systematic Review and Preliminary Meta-Analysis of Preclinical and Clinical Evidence 286
Lessons learnt while designing and conducting a longitudinal study from the first Italian COVID-19 pandemic wave up to 3 years 281
Prenatal insomnia disorder may predict concurrent and postpartum psychopathology: A longitudinal study 202
Occupational Stress Among Italian Postgraduate Medical Trainees: A Pilot Study for the Validation of the SCOPE Questionnaire 185
Challenges in addressing youth mental health 181
In Web We Trust: The Promised Cannabidiol Effects on Obesity as a Matter of Language and Marketing on Webpages 179
Impact of COVID-19 on behavior in autism spectrum disorder 174
Mental health symptoms one year after acute COVID-19 infection: prevalence and risk factors 119
The Supplementation Therapy in Autism and Response to Treatment (START) Study: An Open-Label Feasibility Trial of Ultramicronized Palmitoylethanolamide Potential to Alleviate Psychic Distress among Autistic Adults 114
Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis 113
Disturbi d’ansia 106
Palmitoylethanolamide and its biobehavioral correlates in autism spectrum disorder: A systematic review of human and animal evidence 105
Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence 98
21.5 Repercussions of the First and Second COVID-19 Waves in the Italian Pediatric Population: An Inpatient Psychiatric Emergency Study 96
51.18 THE COVID-19 OUTBREAK IMPACT ON WELL-BEING AMONG PEOPLE WITH AUTISM SPECTRUM DISORDER IN ITALY: AN N = 527 WEB-BASED SURVEY 95
CaReL Guideline: A Consensus-Based Guideline on Case Reports and Literature Review (CaReL) 94
Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence 94
Assessing the biobehavioral effects of ultramicronized-palmitoylethanolamide monotherapy in autistic adults with different severity levels: a report of two cases 92
Mentalization in young patients undergoing opioid agonist treatment: Implications for clinical management 92
Feigning Capgras Syndrome and Developmental Prosopagnosia: a rare case of Pediatric Factitious Disorder 91
Confirmation of increased and more severe adolescent mental health-related in-patient admissions in the COVID-19 pandemic aftermath: A 2-year follow-up study 90
4.4 IS ALTERED SENSORIMOTOR INTEGRATION A CORE FEATURE OF TOURETTE'S DISORDER? A CASE-CONTROL STUDY 90
Lessons Learnt From Running a Transition-Age Youth Mental Health Outpatient Clinic in Italy: The PRecocity of Intervention in Adolescent Medicine (PRIMA) Experience 87
COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomes 85
COVID-19 Survivors Are Still in Need of Neuropsychiatric Support Two Years after Infection 83
Cannabis use and the development of tolerance: a systematic review of human evidence 83
The 2019 Schizophrenia International Research Society Conference, 10–14 April, Orlando, Florida: A summary of topics and trends 81
Can we interrogate public databases to fill critical gaps in mental health epidemiology? Testing the association between cannabis and psychosis in the UK as an example 80
Biobehavioral Interactions between Endocannabinoid and Hypothalamic-pituitary-adrenal Systems in Psychosis: A Systematic Review 79
Palmitoylethanolamide supplementation for human health: A state-of-the-art systematic review of Randomized Controlled Trials in patient populations 79
Adolescent lifestyle behaviors, coping strategies and subjective wellbeing during the covid-19 pandemic: An online student survey 79
The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System 79
Prevalence and risk factors for depression in factitious disorder: a systematic review 76
Editorial: Case reports in autism 75
Additional evidence for neuropsychiatric manifestations in mosaic trisomy 20: A case report and brief review 75
Cannabis and cognition: Connecting the dots towards the understanding of the relationship 74
Post-COVID-19 Syndrome as Described by Patients: A Qualitative Study 73
Attachment styles in transsexual patients and clinical and nonclinical control groups: A Response 73
Tic-Related Obsessive-Compulsive and Eating Disorders in Dandy-Walker Variant: A Case Report and Systematic Reappraisal of Psychiatric Profiles 73
Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains 72
The Moderating Role of Genetic and Environmental Risk Factors for Schizophrenia on the Relationship between Autistic Traits and Psychosis Expression in the General Population 71
Clinical heterogeneity of feeding and eating disorders: using personality psychopathology to differentiate “simplex” and “complex” phenotypes 71
A prediction modelling and pattern detection approach for the first-episode psychosis associated to cannabis use 71
Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis 70
Evidence for endocannabinoid-like compound supplementation for human health 69
Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults 69
Neurobiological underpinnings of the effects of cannabinoids 68
Effectiveness of equine-assisted activities and therapies for improving adaptive behavior and motor function in autism spectrum disorder 68
Vortioxetine Add-On to Methylphenidate for the Treatment of Symptoms of Sickness Behavior in Attention-Deficit Hyperactivity Disorder: Report of Two Cases 67
The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic 67
Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence 67
Using Metaphors to Understand Suffering in COVID-19 Survivors: A Two Time-Point Observational Follow-Up Study 66
Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria 66
Further evidence on the interplay between benzodiazepine and Z-drug abuse and emotion dysregulation 65
Prevention in Mental Health: From Risk Management to Early Intervention 64
Pediatric emergency department mental health assessments in the 2 years following the COVID-19 outbreak reveal higher vulnerability for eating disorder and suicide risk 64
Medically unexplained symptoms in the times of COVID-19 pandemic: A case-report 64
Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network analyses 63
Postural control in childhood: Investigating the neurodevelopmental gradient hypothesis 63
Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids 63
Cannabis and psychosis: What do we know and what should we do? 62
Sociodemographic and clinical changes in pediatric in-patient admissions for mental health emergencies during the COVID-19 pandemic: March 2020 to June 2021 62
Where Do Neurodevelopmental Disorders Go? Casting the Eye Away from Childhood towards Adulthood 60
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study 60
Editorial: Methods and applications in addiction psychiatry research: 2021 59
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study 59
The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task 59
The effectiveness of lurasidone add-on for residual aggressive behavior and obsessive symptoms in antipsychotic-treated children and adolescents with tourette syndrome: Preliminary evidence from a case series 59
Changes in Revolving-Door Mental Health Hospitalizations during the COVID-19 Pandemic: A 5-Year Chart Review Study 59
Risk of psychosis in autism spectrum disorder individuals exposed to psychosocial stressors: A 9-year chart review study 58
Expert consensus riguardante cannabis, cannabinoidi e prodotti derivati 58
Psychological factors associated with vaccination hesitancy: an observational study of patients hospitalized for COVID-19 in a later phase of the pandemic in Italy 57
Cannabis and Psychosis 57
Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study 57
The Endocannabinoid Activity Remodulation for Psychosis Liability in Youth (EARLY) Study: An Open-Label Feasibility Trial of Ultramicronized-Palmitoylethanolamide Oral Supplementation in Clinical High-Risk State for Psychosis 57
Collaborative Outcomes Study on Health and Functioning During Infection Times (COH-FIT): Global and Risk-Group Stratified Course of Well-Being and Mental Health During the COVID-19 Pandemic in Adolescents 56
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence 56
Transsexual patients' psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: Results from a longitudinal study 56
Defining the Scientist: A Consensus-Based Approach 55
Un adolescente con insolita sintomatologia ai tempi del COVID-19 54
Is a No-Restraint Policy Associated with Increased Aggression Towards Healthcare Professionals Among Inpatient Psychiatric Units? A 16-Year Retrospective Observational Study Conducted in Italy 54
Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: A 2year follow-up study 54
Psico-oncologia e psichiatria in medicina palliativa 53
Investigating gait, movement, and coordination in children with neurodevelopmental disorders: Is there a role for motor abnormalities in atypical neurodevelopment? 53
Evaluating psychobiological and mental distress in transsexualism before and after cross-sex hormonal treatment: Lesson learned from three longitudinal studies 53
Substance use, medication adherence and outcome one year following a first episode of psychosis 53
Lo stigma nella salute mentale 53
Cannabidiol (CBD) Listed as a Drug of Abuse by the Italian Health Ministry: Expert Opinion 52
Global and risk-group stratified well-being and mental health during the COVID-19 pandemic in adults: Results from the international COH-FIT Study 52
Cannabis users are less sensitive to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol administration 51
Epigenetic Regulation and Genetic Variation of AKT1 Predict Prefrontal Physiology 51
The Relationship Between Dissociative Experiences and Cannabis Use: a Systematic Review 51
Trends in suicide attempts and deaths in Northeast Italy (2014 to 2023): A rising burden among young women 51
Association between stressful life events and psychosis relapse: a 2-year prospective study in first-episode psychosis 50
Psychological Interventions Tailored to the Needs of Individuals With Hearing and Visual Impairments: What Do We Know and What Should We Do? A Commentary on “A Systematic Review and Meta-Analysis of Psychological Interventions for Persons With Hearing or Vision Impairment: Research Gaps and Call to Action” 50
Editorial: Developmental trajectories in mental health between adolescence and adulthood 50
Poster #M195 THE INTERACTION BETWEEN CNR1 GENETIC VARIATION AND CANNABIS EXPOSURE PREDICTS PREFRONTAL FUNCTIONAL CONNECTIVITY AND BEHAVIOR DURING WORKING MEMORY 50
Interaction between functional genetic variation of DRD2 and cannabis use on risk of psychosis 50
Dissociative symptoms in individuals with gender dysphoria: Is the elevated prevalence real? 50
Cannabis: Neuropsychiatry and its effects on brain and behavior 50
Totale 7.910
Categoria #
all - tutte 50.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.420


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022463 0 0 0 0 0 0 92 175 0 0 41 155
2022/2023745 87 13 27 88 63 177 34 56 93 35 43 29
2023/2024458 47 40 14 12 29 20 37 91 42 44 41 41
2024/20253.796 106 151 146 99 85 184 214 190 347 258 900 1.116
2025/20264.755 451 470 493 590 729 401 693 248 316 364 0 0
Totale 10.217